CFL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.909600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.262600E-01
Normal-vs-Stage2
6.235800E-01
Normal-vs-Stage3
2.681500E-02
Normal-vs-Stage4
7.266400E-02
Stage1-vs-Stage2
8.016400E-01
Stage1-vs-Stage3
2.764400E-01
Stage1-vs-Stage4
4.292600E-01
Stage2-vs-Stage3
1.338580E-01
Stage2-vs-Stage4
7.466200E-01
Stage3-vs-Stage4
6.232400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.005600E-01
Normal-vs-AfricanAmerican
1.901180E-01
Normal-vs-Asian
6.519000E-01
Caucasian-vs-AfricanAmerican
7.963200E-01
Caucasian-vs-Asian
9.104600E-01
AfricanAmerican-vs-Asian
8.677200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.408600E-01
Normal-vs-Female
6.692800E-01
Male-vs-Female
5.064000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.257380E-01
Normal-vs-Age(41-60Yrs)
5.799800E-01
Normal-vs-Age(61-80Yrs)
6.315600E-01
Normal-vs-Age(81-100Yrs)
1.229820E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.458800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.066600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.086000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.740400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.200800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.012200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.991900E-02
Normal-vs-Daily Drinker
7.079200E-03
Normal-vs-Weekly Drinker
8.201800E-01
Normal-vs-Occasional Drinker
1.313420E-01
Normal-vs-Social Drinker
7.207600E-01
Non Drinker-vs-Daily Drinker
9.631200E-01
Non Drinker-vs-Weekly Drinker
2.309600E-01
Non Drinker-vs-Occasional Drinker
2.849400E-01
Non Drinker-vs-Social Drinker
1.863400E-01
Daily Drinker-vs-Weekly Drinker
2.347600E-01
Daily Drinker-vs-Occasional Drinker
2.945600E-01
Daily Drinker-vs-Social Drinker
1.884410E-01
Weekly Drinker-vs-Occasional Drinker
4.304000E-01
Weekly Drinker-vs-Social Drinker
5.688400E-01
Occasional Drinker-vs-Social Drinker
2.745600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.247200E-01
Normal-vs-Grade 2
5.119400E-01
Normal-vs-Grade 3
7.256800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.094600E-01
Grade 1-vs-Grade 3
2.866800E-01
Grade 1-vs-Grade 4
7.247200E-01
Grade 2-vs-Grade 3
1.239780E-01
Grade 2-vs-Grade 4
5.119400E-01
Grade 3-vs-Grade 4
7.256800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.273600E-01
Normal-vs-NonDiabetic
5.218400E-01
Diabetic-vs-NonDiabetic
8.679600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.682200E-01
Normal-vs-NoPancreatitis
4.250800E-01
Pancreatitis-vs-NoPancreatitis
6.315800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.172400E-01
Normal-vs-N1
6.193200E-01
N0-vs-N1
6.109800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.246760E-01
Normal-vs-TP53-NonMutant
4.365800E-01
TP53-Mutant-vs-TP53-NonMutant
3.029800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
